incretin mimetic agents glp 1 receptor agonists Incretin-Based Therapies Through the Decades: Molecular Innovations and Clinical Impact Dual and Triple Gut Peptide

Sex differences in GLP-1 RA treatment response Beyond diabetes status, growing evidence also highlights the importance of sex differences in obesity, particularly regarding their impact on the effectiveness and tolerability of GLP-1 RA treatment

10.1136/bmj.315.7109.629 21 FieldE

Nerve and Brain Injury Studies : Experimental data examine potential neuroprotective roles, which relate to recovery from nerve damage in controlled research environments

Promote Continuous Improvement: Findings from audits drive iterative improvements in protocols, training materials, and lab infrastructure

Exenatide Extended-Release: An Updated Review of Its Use in Type 2 Diabetes Mellitus

Pourquoi Choisir le Glutathione Liposomal Gozitepe